Leuprorelin Acetate for Spinal and Bulbar Muscular Atrophy: A Systematic Review of Clinical Efficacy, Long-Term Outcomes, and Safety Considerations.

Wang B, Wang I, Park C, Barkhaus PE, Shirilla D

Open source

DOI
10.1002/mus.70454
Published
2026 Nov 6
Container
Muscle & nerve
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/mus.70454,
  title = {Leuprorelin Acetate for Spinal and Bulbar Muscular Atrophy: A Systematic Review of Clinical Efficacy, Long-Term Outcomes, and Safety Considerations.},
  author = {Wang B and Wang I and Park C and Barkhaus PE and Shirilla D},
  year = {2026},
  journal = {Muscle \& nerve},
  doi = {10.1002/mus.70454},
  url = {https://doi.org/10.1002/mus.70454}
}

RIS

TY  - JOUR
TI  - Leuprorelin Acetate for Spinal and Bulbar Muscular Atrophy: A Systematic Review of Clinical Efficacy, Long-Term Outcomes, and Safety Considerations.
AU  - Wang B
AU  - Wang I
AU  - Park C
AU  - Barkhaus PE
AU  - Shirilla D
PY  - 2026
JO  - Muscle & nerve
DO  - 10.1002/mus.70454
UR  - https://doi.org/10.1002/mus.70454
ER  - 

APA

B, W., I, W., C, P., PE, B., & D, S. (2026). Leuprorelin Acetate for Spinal and Bulbar Muscular Atrophy: A Systematic Review of Clinical Efficacy, Long-Term Outcomes, and Safety Considerations.. Muscle & nerve. https://doi.org/10.1002/mus.70454

Source records